Clarus Therapeutics (Nasdaq: CLRS) filed a registration statement with the U.S. Securities and Exchange Commission today for an Initial Public ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE